| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_99421d280f8b21828ccaea307b80c9ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60e8d5c551499b2c6c7388955bffa2ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4de23267919d9502f106c5badfbd6b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f851726b456a17d57aa09016b7f0e12f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e0044a8832dc32850c9aebaed63a60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77ab24504a8c10b95c48486fb910e3c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27e1ea5f65e8f958e48f1a9d53fdbb45 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-28 |
| filingDate |
2013-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf08436e1ef33381959635dcb6b61c0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_413a3d086385c31a7eadd32fb3f7db97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3d85c1420840ee3f571afb58872d104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1413f830b352e0e56570a440fdeca81a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_352e67db1d11d8e7ad1503481d15b641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59ef977ba86f352d7f3f66b34494482c |
| publicationDate |
2013-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2013158539-A1 |
| titleOfInvention |
Stem cell fusion model of carcinogenesis |
| abstract |
Model systems and methods for exploring mechanisms of carcinogenesis and the acquisition of metastatic ability, and to provide insights into potential therapeutic targets. The systems include and methods involve fusion of a stem cell and a genetically altered cell to evaluate carcinogenesis and metastasis (Fig. 4) and for the discovery and evaluation of new therapeutic targets to inhibit metastasis and other markers of carcinogenesis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104164406-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019216769-A1 |
| priorityDate |
2012-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |